K.V. Vimalnath

582 total citations
45 papers, 437 citations indexed

About

K.V. Vimalnath is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, K.V. Vimalnath has authored 45 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Radiation. Recurrent topics in K.V. Vimalnath's work include Radiopharmaceutical Chemistry and Applications (33 papers), Medical Imaging Techniques and Applications (15 papers) and Medical Imaging and Pathology Studies (7 papers). K.V. Vimalnath is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (33 papers), Medical Imaging Techniques and Applications (15 papers) and Medical Imaging and Pathology Studies (7 papers). K.V. Vimalnath collaborates with scholars based in India and United States. K.V. Vimalnath's co-authors include Sudipta Chakraborty, Ashutosh Dash, Haladhar Dev Sarma, A. Rajeswari, Rubel Chakravarty, Manab Kumar Das, Sujit Kumar Pal, Usha Pandey, Sankha Chattopadhyay and Ajit Shinto and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and Materials Chemistry and Physics.

In The Last Decade

K.V. Vimalnath

41 papers receiving 432 citations

Peers

Countries citing papers authored by K.V. Vimalnath

Since Specialization

Citations

This map shows the geographic impact of K.V. Vimalnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.V. Vimalnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.V. Vimalnath more than expected).

Fields of papers citing papers by K.V. Vimalnath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.V. Vimalnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.V. Vimalnath. The network helps show where K.V. Vimalnath may publish in the future.

Co-authorship network of co-authors of K.V. Vimalnath

This figure shows the co-authorship network connecting the top 25 collaborators of K.V. Vimalnath. A scholar is included among the top collaborators of K.V. Vimalnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.V. Vimalnath. K.V. Vimalnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of low specific activity 90Y produced in a medium flux research reactor in the preparation of radioactive patch for the treatment of skin ailments 2025 ·Journal of Radioanalytical and Nuclear Chemistry ·K.V. Vimalnath, A. Rajeswari, (unknown), (unknown), Sudipta Chakraborty	0
2	[ ⁹⁰ Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to “TheraSphere” for Cost-Effective Treatment of Liver Cancer 2024 ·Cancer Biotherapy and Radiopharmaceuticals ·K.V. Vimalnath, A. Rajeswari, (unknown), Rubel Chakravarty, Haladhar Dev Sarma, Suyash Kulkarni, Ashish Kumar Jha, Ameya Puranik, Venkatesh Rangarajan, Madhumita Goswami, Sudipta Chakraborty	0
3	Multi-dose formulation and clinical deployment of [90Y]Y-labeled hydroxyapatite (HA) microparticles for radiation synovectomy in India– the inherent intricacies 2024 ·Applied Radiation and Isotopes ·K.V. Vimalnath, A. Rajeswari, (unknown), (unknown), Sudipta Chakraborty	1
4	pH-Responsive magnetic nanocarriers for chelator-free bimodal (MRI/SPECT-CT) image-guided chemo-hyperthermia therapy in human breast carcinoma 2024 ·Journal of Materials Chemistry B ·Bijaideep Dutta, Neena G. Shetake, (unknown), Rubel Chakravarty, K.V. Vimalnath, (unknown), Sudipta Chakraborty, Badri N. Pandey, P. A. Hassan, K.C. Barick	2
5	Radiolabeled nanoporous hydroxyapatite microspheres: An advanced material for potential use in radiation synovectomy 2022 ·Materials Chemistry and Physics ·(unknown), Rubel Chakravarty, Jitendra Bahadur, Apurav Guleria, A. Rajeswari, K.V. Vimalnath, (unknown), Debasis Sen, Sudipta Chakraborty	4
6	Facile Synthesis of a Pt(IV) Prodrug of Cisplatin and Its Intrinsically 195mPt Labeled Analog 2021 ·Indian Journal of Nuclear Medicine ·Prasad P. Phadnis, K. Sharma, K.V. Vimalnath, Rubel Chakravarty, Sudipta Chakraborty, Ashutosh Dash, (unknown)	0
7	Ce‐141‐labeled DOTMP: A theranostic option in management of pain due to skeletal metastases 2019 ·Journal of Labelled Compounds and Radiopharmaceuticals ·K.V. Vimalnath, A. Rajeswari, Haladhar Dev Sarma, Ashutosh Dash, Sudipta Chakraborty	5
8	Barium titanate microparticles as potential carrier platform for lanthanide radionuclides for their use in the treatment of arthritis 2018 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Sudipta Chakraborty, K.V. Vimalnath, (unknown), (unknown), Haladhar Dev Sarma, Rubel Chakravarty, (unknown), Pankaj Sinha, Ashutosh Dash	2
9	Multidose formulation of ready-to-use 177Lu-PSMA-617 in a centralized radiopharmacy set-up 2018 ·Applied Radiation and Isotopes ·Sudipta Chakraborty, K.V. Vimalnath, Rubel Chakravarty, Haladhar Dev Sarma, Ashutosh Dash	12
10	A “mix‐and‐use” approach for formulation of human clinical doses of ¹⁷⁷Lu‐DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases 2017 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Sudipta Chakraborty, K.V. Vimalnath, A. Rajeswari, Rubel Chakravarty, Haladhar Dev Sarma, (unknown), Koramadai Karuppusamy Kamaleshwaran, Ajit Shinto, Ashutosh Dash	5
11	Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use ¹⁷⁷ Lu-DOTA-TATE: The Intricate Radiochemistry Aspects 2017 ·Cancer Biotherapy and Radiopharmaceuticals ·Anupam Mathur, (unknown), (unknown), Sudipta Chakraborty, K.V. Vimalnath, (unknown), (unknown), (unknown), (unknown), Sandip Basu, Aruna Korde, Sharmila Banerjee, Ashutosh Dash, (unknown)	6
12	Synthesis and Preclinical Evaluation of ¹⁷⁷ Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma 2015 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Usha Pandey, (unknown), (unknown), Vikram Gota, K.V. Vimalnath, Ashutosh Dash, Grace Samuel	18
13	Radiochemistry, pre-clinical studies and first clinical investigation of 90 Y-labeled hydroxyapatite (HA) particles prepared utilizing 90 Y produced by (n,γ) route 2015 ·Nuclear Medicine and Biology ·K.V. Vimalnath, Sudipta Chakraborty, A. Rajeswari, Haladhar Dev Sarma, J. Nuwad, Usha Pandey, Koramadai Karuppusamy Kamaleshwaran, Ajit Shinto, Ashutosh Dash	15
14	Large scale production of 51Cr for medical application in a medium flux research reactor: A comparative investigation of Szilard–Chalmers process and direct (n,γ) route 2014 ·Applied Radiation and Isotopes ·K.V. Vimalnath, A. Rajeswari, Sudipta Chakraborty, Ashutosh Dash	6
15	141Ce-DOTMP: A theranostic agent for metastatic bone tumor 2014 ·Nuclear Medicine and Biology ·K.V. Vimalnath, A. Rajeswari, Haladhar Dev Sarma, Sudipta Chakraborty	2
16	On the practical aspects of large-scale production of 177Lu for peptide receptor radionuclide therapy using direct neutron activation of 176Lu in a medium flux research reactor: the Indian experience 2014 ·Journal of Radioanalytical and Nuclear Chemistry ·Sudipta Chakraborty, K.V. Vimalnath, (unknown), (unknown), Ashutosh Dash	37
17	Practicality of Production of ³² P by Direct Neutron Activation for Its Utilization in Bone Pain Palliation as Na ₃ [ ³² P]PO ₄ 2013 ·Cancer Biotherapy and Radiopharmaceuticals ·K.V. Vimalnath, (unknown), Sudipta Chakraborty, Tapas Das, (unknown), Haladhar Dev Sarma, K. C. Jagadeesan, Pradeep Joshi	11
18	Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles 2007 ·Applied Radiation and Isotopes ·Sankha Chattopadhyay, K.V. Vimalnath, (unknown), Aruna Korde, Haladhar Dev Sarma, Sujit Kumar Pal, Malay K. Das	24
19	A versatile technique for radiochemical separation of medically useful no-carrier-added (nca) radioarsenic from irradiated germanium oxide targets 2007 ·Applied Radiation and Isotopes ·Sankha Chattopadhyay, Sujit Kumar Pal, K.V. Vimalnath, Manab Kumar Das	19
20	Facile access to 154Eu, a new reference source for calibration in gamma ray spectrometry 2004 ·Applied Radiation and Isotopes ·K.V. Vimalnath, Manab Kumar Das, (unknown), N. Ramamoorthy	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact